Global IVF Market Trends and Opportunities 2021-2026, Featuring Key Players Fertipro, Vitrolife, Thermo Fisher Scientific, Nidacon and Genea

DUBLIN, Dec. 8, 2021 /PRNewswire/ -- The "In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

The global in-vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026.

The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain extent.

COVID-19 triggered the worldwide suspension of in vitro fertilization treatment; this had a profound impact on women undergoing IVF procedures. In India, 30 lakh people seek IVF every year, but only 5 lakh people undergo IVF/intrauterine insemination (IUI) procedures. During the COVID-19 pandemic, a 90% drop was observed in the number of people undergoing IVF cycles. The spread of COVID-19 has not only impacted fertility clinics owing to the cancellation of IVF treatments but has also impacted fertility decisions among couples who had opted for IVF treatment before the pandemic

The equipment to capture the largest share in vitro fertilization market, by products during the forecast period.

The equipment segment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the increasing number of IVF procedures and the introduction of highly advanced IVF equipment by well-established manufacturers in the market.

The fresh non-donor segment to capture the largest market share of in vitro fertilization market, by the type of cycle in 2021.

The fresh non-donor segment captured the largest share of the in vitro fertilization market cycles during the forecast period. High success rates, ease in the implantation process, and enhanced embryo production are responsible for the large share of this segment.

The IVF with ICSI segment registered the highest growth rate of the in vitro fertilization market, by type, in 2021

The IVF with ICSI segment registered the highest growth rate of the in vitro fertilization market. The success rate of fertilization with ICSI procedure, and the growing utilization of the ICSI during IVF procedure are anticipated to boost the adoption of IVF with ICSI procedures, accelerating the growth of the segment during the forecast period.

The fertility clinics segment accounted for the largest share of the in vitro fertilization market, by end user, in 2021

The rising government initiatives to establish fertility clinics, initiatives taken by large international healthcare providers to establish fertility centers, growing popularity of IVF & ICSI treatment globally are some of the factors likely to contribute towards the rapid growth of the segment.

Key Topics Covered:

Executive Summary

• Delayed Pregnancy in Women is Key Growth Driver of IVF Market
• Reagents and Media Segment to Register Highest Growth in In Vitro Fertilization Market During Forecast Period
• Fresh Non-Donor Segment Holds Largest Share of In Vitro Fertilization Market
• IVF with ICSI Segment to Witness Highest Growth in Forecast Period
• Fertility Centers Exhibit Largest Demand for In Vitro Fertilization Products
• Equipment Segment Accounted for Largest Share of In Vitro Fertilization Market in APAC
• APAC Market to Witness Highest Growth During Forecast Period (2021-2026)

Market Dynamics

Drivers

• Increase in Median Age of First-Time Mothers
• Declining Fertility Rate
• Rising Number of Fertility Clinics Worldwide
• Male Infertility on the Rise
• Growing Rate of Obesity and Increased Consumption of Alcohol
• Technological Advancements and Product Innovation
•  Advancements in IVF Devices
• Growing Use of Time-Lapse Technology Worldwide
•  Increasing Public-Private Funding
• Government Initiatives to Promote IVF Treatments

Restraints

• High Costs Associated with IVF Procedures
• Restrictive Regulations and Ethical Concerns

Opportunities

• Growth Opportunities in Emerging Markets
• Increasing Medical Tourism
• Use of Fertility Treatment Options by Single Parents and Same-Sex Couples

Challenges

• Reducing Efficacy of Infertility Treatment Among Patients with Advancing Age

Company Profiles

• Cook Group
• Corning Incorporated
• Dxnow, Inc.
• Eppendorf
• Esco Micro Pte. Ltd.
• Fertipro Nv
• Fujifilm Irvine Scientific
• Genea Limited
• Hamilton Thorne Ltd.
• Invitrocare Inc.
• Ivftech Aps
• Kitazato Corporation
• Microtech Ivf S.R.O.
• Nidacon International Ab
• Sar Healthline Pvt. Ltd.
• The Baker Company, Inc.
• The Cooper Companies Inc.
• Thermo Fisher Scientific
• Vitrolife
• Zeiss Group

For more information about this report visit https://www.researchandmarkets.com/r/offve1

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com